<html>
<head>PUBMED IDs for PRKCB2</head>
<body bgcolor='#C5F0F2'><h1>PRKCB2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22833470/'>PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22833464/'>Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.</a> February 21  2012<br></body></html>
